Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Internet Provides Access to Massive Clone and Antibody Resource

By LabMedica International staff writers
Posted on 06 Jul 2011
An advanced search engine available on the Internet allows researchers to quickly access a clone and antibody resource comprising over 20 million clones and more than 90,000 antibodies.

Source BioScience (Nottingham, United Kingdom) has announced the launch of the largest publicly available clone and antibody resource portfolio for research purposes in the world in conjunction with an innovative, intelligent search engine. More...


Researchers will be able to access over 20 million clones, representing nearly every known human gene and most other organisms important in biological research. In addition, there is a portfolio of over 90,000 antibodies for applications in both research and diagnostics. This vast amount of material is rendered useful through GenomeCube, an intelligent web-based portal that can search the entire Source BioScience clone and antibody portfolio using an array of search terms and common identifiers used in international scientific databases.

Dr. Nick Leaves, COO of Source BioScience, said, “The Source BioScience clone and antibody resource represents an invaluable tool for biological research. Researchers will now be able to locate and buy these products from a single site. In addition, with the launch of our enhanced search engine, GenomeCube, researchers will be able to access this library with comprehensive annotation, and scientific and technical support in a fraction of the time. We believe this one-stop shop will make a significant difference to researchers.”

Related Links:
Source BioScience




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.